1、OUTLOOK,TRENDS&FUTURE MARKETS FOR SINGLE-USECollaboration,technology&innovation:shaping the Collaboration,technology&innovation:shaping the future of singlefuture of single-use use Tuesday July 11th 2023Big Picture Outlook and TrendsSINGLE USE IS DEFINITELY MAINSTREAMINDUSTRY IS MATURING,GETTING MOR
2、E EFFICIENT EXPECTING ITS SUPPLIERS TO SUPPORT PRODUCTIVITYTop Options for Bioreactor Platforms at Commercial Commercial ScaleScale,2023Estimated Percentage of Facilities Unit Operations that are“Single-Use or Disposable”2023 83%of Chinas Upstream BioManufacturing is Single Use New Bioprocessing is
3、mostly SUS at clinical scale.(Chinas bioprocess industry is mostly new).Source:BioPlans 2nd Annual:Chinas Position in Global BioManufacturing A Comparison of Chinas Emerging Position vs Established Regions Manufacturing Capacity and ProductionSingle-Use Vendor Satisfaction,2008-20231717-Year,Percent
4、ageYear,Percentage-point point Increase in Usage of Increase in Usage of DisposablesDisposablesAll Stages R&D&Manufacture,2006All Stages R&D&Manufacture,2006-20232023(Note:Not growth in sales,this is growth in application first usage within a facility)Post-COVID,Whats Driving the Industry?CAPACITY C
5、ONSTRAINTS ARE RETURNING TO NORMALLOOKING TO SINGLE USE TO ADDRESS CAPACITY CHALLENGESINCREASING EXPENDITURES ON SUS20 Years:Capacity Constraints Trends(2004-2023)COVID Severe Constraints 2021-2022Post-COVID 2023I believe our facility is experiencing production capacity constraints todayKey Areas to
6、 Address to Avoid Capacity Constraints(2006-2023)If this industry is to avoid significant capacity constraints,the most important areas to address are:Changes in Bioprocess Consumables OrderingSuppliers vs Biopharmas PerspectivesBiomanufacturer Facility Changes in Ordering for Bioprocess Supplies 20